x
Dartmouth-Hitchcock logo
Summer Flowers In This Section
 
SECURE A Non-Interventional Long-Term Post-Marketing Registry of Patients Treated with Certolizumab Pegol (Cimzia?) for Crohn's Disease
Principal Investigator (?)
Study Number
F09051
Summary
The purpose of this study is to monitor safety outcomes of patients who have taken Cimzia® as compared to a non- Cimzia® control population. The SECURE Registry''s target enrollment is 3045 patients and it''s objective is to monitor patients for approximately 8 years. 
Phase (?)
Phase III
Sponsor (?)
Contact

Laurie Skinner

Available at the following location(s)

Lebanon

View more details from ClinicalTrials.gov.

0